[1]
|
Furusho, K., Kamiya, T., Nakano, H., Kiyosawa, N., Shinomiya, K., Hayashidera, T., et al. (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet, 2, 1055-1058. doi:10.1016/S0140-6736(84)91504-6
|
[2]
|
Newburger, J.W., Takahashi, M., et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. The New England Journal of Medicine, 315, 341-347. doi:10.1056/NEJM198608073150601
|
[3]
|
Newburger, J.W., Takahashi, M., Beiser, A.S., et al. (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. The New England Journal of Medicine, 324, 1633-1639.
doi:10.1056/NEJM199106063242305
|
[4]
|
Burns, J.C., Capparelli, E.V., Brown, J.A., Newburger, J.W. and Glode, M.P. (1988) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatric Infectious Disease Journal, 17, 1144-1148.
doi:10.1097/00006454-199812000-00009
|
[5]
|
Durongpisitkul, K., Soongswang, J., Laohaprasitiporn, D., Nana, A., Prachuabmoh, C. and Kangkagate, C. (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatric Cardiology, 24, 145-148.
doi:10.1007/s00246-002-0216-2
|
[6]
|
Egami, K., Muta, H., Ishii, M., et al. (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. Journal of Pediatrics, 149, 237-240. doi:10.1016/j.jpeds.2006.03.050
|
[7]
|
Han, R.K., Silverman, E.D., Newman, A. and McCrindle, B.W. (2000) Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Archives of Pediatrics & Adolescent Medicine, 154, 694-699.
|
[8]
|
Wallace, C.A., French, J.W., Kahn, S.J. and Sherry, D.D. (2000) Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics, 105, e78-e81.
doi:10.1542/peds.105.6.e78
|
[9]
|
Newburger, J.W., Takahashi, M., et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation, 110, 2747-2771.
doi:10.1161/01.CIR.0000145143.19711.78
|
[10]
|
Wright, D.A., Newburger, J.W., Baker, A. and Sundel, R.P. (1996) Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidss. Jour- nal of Pediatrics, 128, 146-149.
doi:10.1016/S0022-3476(96)70447-X
|
[11]
|
Okada, M., Nakai, S., Kobayashi, Y., et al. (1997) Effects of intravenous gamma globulin and ulinastatin on patients with Kawasaki disease and predicted giant coronary artery aneurysms. Journal of The Japan Pediatric Society, 101, 1165-1170.
|
[12]
|
Mori, M., Tomono, N. and Yokota, S. (1995) Coronary arteritis of Kawasaki disease unresponsive to high-dose intravenous gammaglobulin successfully treated with plasmapheresis. Nihon Rinsho, 18, 282-288.
doi:10.2177/jsci.18.282
|
[13]
|
Research Committee on Kawasaki Disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo.
|
[14]
|
Sundel, R.P., Burns, J.C., Baker, A., Beiser, A.S. and Newburger, J.W. (1993) Gamma globulin re-treatment in Kawasaki disease. Journal of Pediatrics, 123, 657-659.
doi:10.1016/S0022-3476(05)80972-2
|
[15]
|
Raman, V., Kim, J., Sharkey, A. and Chatila, T. (2001) Response of refractory Kawasaki disease to pulse steroids and cyclosporin A therapy. Pediatric Infectious Disease Journal, 20, 635-637.
doi:10.1097/00006454-200106000-00022
|
[16]
|
Lee, M.S., An, S.Y., Jang, G.C. and Kim, D.S. (2002) A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate. Yonsei Medical Journal, 43, 527-532.
|
[17]
|
Weiss, J.E., Eberhard, B.A., Chowdhury, D. and Gottlieb, B.S. (2004) Infliximab as a novel therapy for refractory Kawasaki disease. Journal of Rheumatology, 31, 808-810.
|
[18]
|
Burns, J.C., Mason, W.H., et al. (2005) Infliximab treatment for refractory Kawasaki syndrome. Journal of Pediatrics, 146, 662-667. doi:10.1016/j.jpeds.2004.12.022
|
[19]
|
Kato, H., Koike, S. and Yokoyama, T. (1979) Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics, 63, 175-179.
|
[20]
|
Furukawa, T., Kishiro, M., et al. (2008) Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Archives of Disease in Childhood, 93, 142-146.
doi:10.1136/adc.2007.126144
|